Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Virus

05.01.2023

NoctuRNA Therapeutics: a spin-off for broad-spectrum antivirals

27.12.2022

NOVIRUSES2BRAIN: A project to develop «smugglers» capable of crossing physiological barriers to attack viruses

04.11.2022

Individualized follow-up of COVID-19 vaccine for some HIV patients

16.09.2022

Viruses reprogram cellular tRNAs to maximize viral production

01.03.2022

What is the relationship between bacteriophages in our microbiota and our cognitive capacity?

17.11.2021

Discovered a new mechanism against Epstein-Barr virus infection

31.05.2021

The crown of the king of viruses

31.03.2021

Viruses adaptation to the tissues they infect

03.03.2021

Identified a specific region of SARS-CoV-2 useful for the diagnosis of COVID-19 and vaccine development

Pulmobiotics is a CRG spin-off that aims to develop therapeutic applications for lung diseases. Photo by Robina Weermeijer on Unsplash.
27.07.2020

Pulmobiotics: transforming a pathogen to fight lung disease

Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial. | Picture by ISGlobal.
21.05.2020

New study to assess the efficacy of ivermectin against COVID-19

Untrained staff performing the test will get an unequivocal result from the instrument. | Picture by the UPF.
15.05.2020

InstaCOVID19: UPF develops rapid diagnostic tests for SARS-CoV-2

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2023 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

You are subscribing to receive the newsletter in English. If you would like to receive it in Catalan or Spanish, please change the language settings in our web.

PRBB will use the information you provide on this form to be in touch with you and to provide updates. By clicking below to subscribe, you accept our privacy policy. You can unsubscribe at any time.